A REVIEW OF KETAMINE FOR DEPRESSION

Ketamine is classified as a Schedule III managed compound under the Managed Compound Act and, as pointed out higher than, approved with the FDA for anesthetic indications [73]. Common adverse effects involved with anesthetic ketamine use consist of emergence reactions, hemodynamic instability, and respiratory depression. These indications are reall